495 related articles for article (PubMed ID: 22012077)
1. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C
Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077
[TBL] [Abstract][Full Text] [Related]
2. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
Miller CL; Oikawa M; Cai Y; Wojtovich AP; Nagel DJ; Xu X; Xu H; Florio V; Rybalkin SD; Beavo JA; Chen YF; Li JD; Blaxall BC; Abe J; Yan C
Circ Res; 2009 Nov; 105(10):956-64. PubMed ID: 19797176
[TBL] [Abstract][Full Text] [Related]
3. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
4. The PDE1A-PKCalpha signaling pathway is involved in the upregulation of alpha-smooth muscle actin by TGF-beta1 in adventitial fibroblasts.
Zhou HY; Chen WD; Zhu DL; Wu LY; Zhang J; Han WQ; Li JD; Yan C; Gao PJ
J Vasc Res; 2010; 47(1):9-15. PubMed ID: 19672103
[TBL] [Abstract][Full Text] [Related]
5. MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A.
Ren L; Yang C; Dou Y; Zhan R; Sun Y; Yu Y
Exp Lung Res; 2017; 43(6-7):249-258. PubMed ID: 28816543
[TBL] [Abstract][Full Text] [Related]
6. Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.
Hashimoto T; Kim GE; Tunin RS; Adesiyun T; Hsu S; Nakagawa R; Zhu G; O'Brien JJ; Hendrick JP; Davis RE; Yao W; Beard D; Hoxie HR; Wennogle LP; Lee DI; Kass DA
Circulation; 2018 Oct; 138(18):1974-1987. PubMed ID: 30030415
[TBL] [Abstract][Full Text] [Related]
7. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
8. A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction.
Chen S; Zhang Y; Lighthouse JK; Mickelsen DM; Wu J; Yao P; Small EM; Yan C
Circulation; 2020 Jan; 141(3):217-233. PubMed ID: 31801360
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
11. Ca(2+)/calmodulin-activated phosphodiesterase 1A is highly expressed in rabbit cardiac sinoatrial nodal cells and regulates pacemaker function.
Lukyanenko YO; Younes A; Lyashkov AE; Tarasov KV; Riordon DR; Lee J; Sirenko SG; Kobrinsky E; Ziman B; Tarasova YS; Juhaszova M; Sollott SJ; Graham DR; Lakatta EG
J Mol Cell Cardiol; 2016 Sep; 98():73-82. PubMed ID: 27363295
[TBL] [Abstract][Full Text] [Related]
12. Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival.
Nagel DJ; Aizawa T; Jeon KI; Liu W; Mohan A; Wei H; Miano JM; Florio VA; Gao P; Korshunov VA; Berk BC; Yan C
Circ Res; 2006 Mar; 98(6):777-84. PubMed ID: 16514069
[TBL] [Abstract][Full Text] [Related]
13. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
[TBL] [Abstract][Full Text] [Related]
14. TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation.
Adapala RK; Kanugula AK; Paruchuri S; Chilian WM; Thodeti CK
Basic Res Cardiol; 2020 Jan; 115(2):14. PubMed ID: 31925567
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.
Medzikovic L; Heese H; van Loenen PB; van Roomen CPAA; Hooijkaas IB; Christoffels VM; Creemers EE; de Vries CJM; de Waard V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562500
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of cAMP accumulation in adult rat cardiac fibroblasts by IL-1beta and NO: role of cGMP-stimulated PDE2.
Gustafsson AB; Brunton LL
Am J Physiol Cell Physiol; 2002 Aug; 283(2):C463-71. PubMed ID: 12107056
[TBL] [Abstract][Full Text] [Related]
18. Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis.
Lu D; Aroonsakool N; Yokoyama U; Patel HH; Insel PA
Mol Pharmacol; 2013 Dec; 84(6):787-93. PubMed ID: 24085841
[TBL] [Abstract][Full Text] [Related]
19. PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries.
Khammy MM; Dalsgaard T; Larsen PH; Christoffersen CT; Clausen D; Rasmussen LK; Folkersen L; Grunnet M; Kehler J; Aalkjaer C; Nielsen J
Br J Pharmacol; 2017 Nov; 174(22):4186-4198. PubMed ID: 28910498
[TBL] [Abstract][Full Text] [Related]
20. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
